Thus, another explanation was that PNPLA3, which has been linked to multiple lipid metabolic processes and liver fibrosis, bridged the association between BA metabolism and MASLD development. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.